-
This app is based on a Kaggle competition called RSNA-MICCAI Brain Tumor Radiogenomic Classification, which is organized by Radiological Society of North America (RSNA).
-
The app aims to predict the status of a genetic biomarker (MGMT promoter methylation) which is important for choosing the brain cancer treatment.
-
MGMT promoter methylation is the key mechanism of MGMT gene silencing and predicts a favourable outcome in patients with glioblastoma who are exposed to alkylating agent chemotherapy.
-
The model training is done using this Kaggle notebook
-
The model is trained based on this competition dataset